Drug Profile
SELA 070
Alternative Names: SELA070Latest Information Update: 05 Dec 2023
Price :
$50
*
At a glance
- Originator Selecta Biosciences
- Developer Cartesian Therapeutics
- Class Conjugate vaccines; Synthetic vaccines; Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Smoking withdrawal
Most Recent Events
- 28 Jun 2020 No recent reports of development identified for phase-I development in Smoking-withdrawal(In volunteers) in Belgium (SC, Injection)
- 18 Oct 2018 Selecta Biosciences completes a phase I trial in Smoking withdrawal (In volunteers) in Belgium (SC) (NCT03148925)
- 25 Apr 2018 Selecta Biosciences has patent protection for SELA 070 for Smoking withdrawal